Recent molecular biological studies have revealed frequent genetic alterations in three tumor suppressor genes, neurofibromatosis 2 (NF2), cyclin-dependent kinase inhibitor 2 A (CDKN2A, p16), and BAP1 in MMe [3, 4, 9, 10]. This evidence concerns the gene CDKN2A and neoplasm.